BAKX Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- BAKX Therapeutics's estimated annual revenue is currently $930k per year.
- BAKX Therapeutics's estimated revenue per employee is $77,500
- BAKX Therapeutics's total funding is $25M.
Employee Data
- BAKX Therapeutics has 12 Employees.
- BAKX Therapeutics grew their employee count by -40% last year.
BAKX Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Chief Computational Scientist | Reveal Email/Phone |
4 | VP, Head Bioinformatics and Translational Sciences | Reveal Email/Phone |
5 | Head Protein Sciences | Reveal Email/Phone |
6 | Head Discovery Biology | Reveal Email/Phone |
7 | Head Translational Sciences & Bioinformatics | Reveal Email/Phone |
8 | Director Finance And Operations | Reveal Email/Phone |
9 | Senior Lab & Research Operations Manager | Reveal Email/Phone |
10 | Acting General Counsel | Reveal Email/Phone |
BAKX Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is BAKX Therapeutics?
We create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations We have built an integrated & iterative platform based on knowledge, experimentation, and simulation that allows us to better interrogate and harness the power of regulated apoptosis We are developing a suite of orally active therapeutics which can act as single agents or in combination with other oncology therapies to create better and lasting outcomes for cancer patients
keywords:N/A
$25M
Total Funding
12
Number of Employees
$930k
Revenue (est)
-40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BAKX Therapeutics News
... chair of the scientific advisory board of Bakx Therapeutics Inc., ... In the therapeutic world, activators have historically been much...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.2M | 12 | -77% | $263.3M |
#2 | $1.1M | 12 | 0% | N/A |
#3 | $0.9M | 12 | -29% | N/A |
#4 | $1M | 12 | 9% | N/A |
#5 | $1M | 12 | N/A | N/A |